GlassScriptPhysician profile
Troy S Johnson
NPI 1730197252
$1,269.32
in general payments reported to CMS, 2019-2025
22 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $425 · 2023: $198 · 2024: $199 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $430.55 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Abbvie INC. | $215.86 | 2022-2025 | |
| Nalu Medical, INC. | $68.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $52.91 | 2024-2025 | Breztri, Airsupra |
| Pfizer INC. | $52.66 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $47.39 | 2021 | |
| Horizon Therapeutics Plc | $44.72 | 2022 | |
| Avanos Medical | $44.10 | 2025 | Generator |
| Collegium Pharmaceutical, INC. | $37.24 | 2021 | |
| Ferring Pharmaceuticals INC. | $32.79 | 2021-2022 | |
| Novo Nordisk INC | $31.41 | 2024-2025 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $28.72 | 2022 | |
| Exact Sciences Corporation | $28.68 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $26.00 | 2022-2023 | Quviviq |
| Indivior INC. | $21.36 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.12 | 2024 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2022 | |
| Lundbeck LLC | $15.75 | 2022 | |
| Almatica Pharma LLC | $15.49 | 2021 | |
| Abbott Laboratories | $15.32 | 2021 | |
| Organon LLC | $14.31 | 2024 | |
| Stimwave Technologies Incorporated | $8.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.